- Home
- NRSN vs DXLG Comparison
NRSN vs DXLG Comparison
Compare NRSN & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | DXLG |
|---|---|---|
| Founded | 2017 | 1976 |
| Country | Israel | United States |
| Employees | 15 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 24.1M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | NRSN | DXLG |
|---|---|---|
| Price | $0.78 | $0.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.50 | $1.50 |
| AVG Volume (30 Days) | 187.1K | ★ 215.7K |
| Earning Date | 03-20-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $435,017,000.00 |
| Revenue This Year | N/A | $3.85 |
| Revenue Next Year | N/A | $4.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.44 |
| 52 Week High | $2.60 | $1.69 |
Technical Indicators
Market Signals| Indicator | NRSN | DXLG |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 50.45 |
| Support Level | $0.66 | $0.49 |
| Resistance Level | $1.30 | $0.57 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 65.26 | 38.24 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.